The article discusses the potential of fecal microbiota transplantation (FMT) in restoring gut barrier function and immunity in patients with cirrhosis. Cirrhosis is a condition characterized by liver damage and is associated with intestinal barrier dysfunction, leading to increased bacterial translocation and immune system activation. FMT involves the transfer of healthy fecal microbiota from a donor to a recipient, with the aim of restoring a balanced gut microbiome.
Author: Abhay Panchal
The article highlights the current state of physicians in the U.S. healthcare system and discusses the challenges they face. It mentions that physician income has not kept pace with inflation and administrative costs, leading to a significant number of physicians leaving private practice. Many are now employed by hospitals or private equity-backed practice managers. The article points out that hospitals and drug companies have successfully protected their interests while physicians have lost ground financially.
A recent pilot study in the United States has tested a new technology called magnetically controlled capsule endoscopy, which aims to improve the diagnosis of stomach pain in emergency room patients. Currently, traditional methods like scans and ultrasounds cannot provide a clear view of the inner lining of the digestive tract, resulting in patients being sent home without answers. Upper endoscopies, which can visualize the digestive tract, require anesthesia and are typically performed by gastroenterologists, leading to potential delays in diagnosis and treatment of serious conditions such as gastric cancer or bleeding ulcers.
Welcome to our new series Microbiome Minute, where experts from the AGA Center for Gut Microbiome Research & Education break down the most interesting research developments in this space with 1-minute summaries. Today’s Microbiome MinuteDr. Phillip Tarr, chair of AGA’s microbiome center, provides a review of the article, “Gut microbiome composition is associated with future onset of Crohn’s disease in healthy first-degree relative”, published in Gastroenterology by Juan Raygoza Garay, et al.
The federal healthcare Anti-Kickback Statute targets bribery and corruption within healthcare, according to a June 13 post from JD Supra. About the Anti-Kickback Statute The law’s two provisions target the bribe recipient and the bride payer. The statute prohibits remuneration for healthcare referrals or purchases reimbursable under a federal health insurance program as well as remuneration to encourage healthcare referrals or purchases reimbursable under a federal program.
Alba Health, a Danish-Swedish start-up dedicated to providing digital gut health support for children, announced today that it has secured $2 million in pre-seed funding, in a round led by Voima Ventures, including Octopus Ventures, Noaber, Bust VC, Joyance Partners, and the cofounders of Oura. This follows financial support of $500,000 by the BioInnovation Institute, a Novo Nordisk Foundation initiative, bringing the total financing of Alba Health to $2.5 million in 2023.
The article discusses the work of Sonia Grego, the director of Duke University’s Smart Toilet Lab, which is focused on researching smart toilet technologies. The lab is part of Duke’s Center for Water, Sanitation, Hygiene, and Infectious Disease (WaSH-AID). Grego and her nine-person team are dedicated to addressing health issues related to human waste and aim to demystify the taboo surrounding discussions about poop.
Northwestern Medicine physicians who used artificial intelligence to perform colonoscopies saw a 13 percent increase in colorectal polyps detection and removal, according to research posted May 10 from the Evanston, Ill.-based health system.
FRIDAY, May 5, 2023 (HealthDay News) — Approximately two-thirds of patients with inflammatory bowel disease (IBD) report the partial or total exclusion of at least one food category, according to a study published online April 20 in the United European Gastroenterology Journal. Olivier Bonsack, from the University of Lorraine and Nancy University Hospital in France, and colleagues conducted an anonymous survey of 434 patients with IBD to characterize the prevalence of exclusion diets and fasting and to identify associated risk factors.
MENLO PARK, Calif., June 20, 2023 — GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, and the University of Oxford today announced that results from the SYMPLIFY study have been published in The Lancet Oncology. SYMPLIFY is the first large-scale evaluation of a multi-cancer early detection (MCED) test in individuals who presented with symptoms to primary care and were referred for diagnostic follow-up for suspicion of cancer. The analysis showed strong performance of GRAIL’s MCED methylation-based platform in the population of more than 6,000 patients and demonstrated the feasibility of using…